Mini Program: A-share pre-market news express.
Important news.
1. The Cyberspace Administration strictly cracks down on online financial chaos: a strong response to illegal stock recommendations and misleading loan assistance behavior.
Since the beginning of this year, the National Cyberspace Administration has thoroughly implemented the work deployment of the Central Committee and the State Council, maintaining a high-pressure crackdown on online financial information chaos. It has worked with relevant departments to handle a batch of accounts engaged in illegal stock recommendations, illegal financial intermediaries, and other activities on platforms such as Douyin, Kuaishou, Weibo, and WeChat, cleaning up financial-related misleading and inducing illegal information and increasing the penalties on websites and accounts engaged in financial-related businesses without qualifications. For websites and platforms engaged in loan assistance, they are required to standardize the display of marketing information and marketing function settings and strengthen information risk disclosure. In the next step, the National Cyberspace Administration will continue to strengthen the crackdown on online financial information chaos, standardize the dissemination order of online financial information, and strive to safeguard the property safety of the people. (Cyberspace China)
2. Personal pension expansion and upgrade: Pilot coverage expands nationwide and adds more than 20 broad-based index funds.
The personal pension pilot will soon be fully opened, expanding from the original 36 pilot cities to nationwide. At the same time, personal pension fund products are also expanding, with some mature broad-based ETF linked funds and broad-based index off-market products to add Y shares. It is reported that the products eligible for personal pension investments may include off-market products tracking nearly 20 broad-based indices, such as the CSI 300 Index, CSI 500 Index, CSI 800 Index, GEM Index, and STAR 50 Index. (21 Finance)
3. Financial Times: The pressure from a strong U.S. dollar is expected to weaken, and the RMB is likely to stabilize and recover by the end of the year.
The central bank's supervisory media (Financial Times) published a commentary article stating that recently, market speculation around Donald Trump's trade following the U.S. elections has significantly boosted the U.S. dollar index, breaking through 108 at its highest, putting pressure on non-dollar currencies. The RMB exchange rate fluctuates in both directions and its elasticity has increased, with market expectations being relatively stable, and corporate purchase and sale of foreign exchange behavior being rational and orderly, resulting in an overall smooth operation of the foreign exchange market. Several industry experts believe that the possibility of a decline in the U.S. dollar is increasing, and China's economic development is stable and improving. Considering the internal and external conditions, the RMB exchange rate is expected to maintain basic stability at a reasonable and balanced level, and with the increase in corporate foreign exchange settlements towards the end of the year, it is highly likely to stabilize and rise.
4. The tenth batch of national procurement starts: 62 varieties open bidding, with scale hitting a new high, and multiple heavyweight varieties over 2 billion participating in bidding.
The tenth batch of national organized drug centralized procurement officially accepted enterprise declaration materials today at 8 a.m. at 398 Zhan Yuan Road, Nanqiao New City, Fengxian District, Shanghai. This centralized procurement involves 62 varieties and 263 specifications, with both the number of enterprises and varieties involved reaching a historical high. Among them, there are 33 companies competing for the qualification of the oral sustained-release formulation of Sitagliptin, as well as multiple varieties that are billion-level in the public hospital market, such as Doxorubicin Liposome Injection, Lacosamide Injection, Piperacillin Injection, Compound Alpha-Keto Acid Oral Sustained-Release Formulation, Norepinephrine Injection, and Aspirin Oral Sustained-Release Formulation, all of which exceeded 2 billion yuan in sales scale in last year's sample hospitals. Heng Rui Pharmaceutical, Kelun Pharmaceutical, Shiyao Group, and Zhengda Tianqing are participating with multiple varieties. According to the previously issued tenth batch of national procurement documents, there are significant changes in the rules for the tenth batch of national procurement, such as the cancellation of the 50% price reduction protection mechanism and the addition of a 1.8-fold circuit breaker revival mechanism, with the number of B certificate enterprises affecting the final number of enterprises qualified.
5. The U.S. Department of Commerce placed two Chinese high-tech companies on the 'Entity List' under the pretext of 'human rights violations.' The Ministry of Foreign Affairs responded: It is a blatant attempt to suppress Chinese high-tech companies under the guise of human rights.
On December 11, the Ministry of Foreign Affairs spokesperson Mao Ning hosted a regular press conference. On December 10, the U.S. Department of Commerce placed two Chinese high-tech companies on the 'Entity List' under the pretext of 'human rights violations.' What is China's comment on this? Mao Ning: The so-called sanctions you mentioned are a blatant attempt to suppress Chinese high-tech companies under the guise of human rights, further exposing the U.S. side's hypocrisy in protecting human rights while genuinely depriving the Chinese people of their right to develop. Such tricks will not succeed. If the U.S. truly cares about human rights, it should first address its own 'debts' in human rights rather than politicizing and weaponizing human rights issues, interfering in the internal affairs of other countries, and harming the interests of other nations. (Ministry of Foreign Affairs)
Individual stock news.
1. Zhuoran Co.: The significant order change reduced the original order from 6.936 billion yuan to 157 million yuan.
Zhuoran Co. announced that its wholly-owned subsidiary Zhuoshu signed a fine chemical equipment-related order contract with Zhenhua Petroleum on April 14, 2023, with an original total order amount of 6.936 billion yuan. Due to changes in various factors such as market supply and demand, on December 6, 2024, the company received a notice from Zhenhua Petroleum regarding project adjustments and subsequent changes. After friendly consultation with the owner, on December 10, 2024, they signed the 'Settlement Agreement for the Main Device and Supporting Modular Design and Manufacturing Installation for Zhenhua Petroleum Chemical Co., Ltd. 260,000 tons/year Maleic Anhydride Main Device' and the 'Contract Termination Agreement for the Modular Design, Manufacturing, and Installation EPC Project for the 400,000 tons/year Butane Reaction Unit and 300/670,000 tons/year PO/SM Main Device and its Supporting Modular Design, Manufacturing, and Installation EPC Project' with the owner. The above agreements take effect from the date of signing, and the final settlement amount after the order change is 157 million yuan.
2. Liangpinpuzi: Shareholder Dayong Limited has cumulatively reduced its stake in the company by 3%, and the reduction plan has been completed.
Liangpinpuzi announced that from October 31 to December 10, 2024, shareholder Dayong Limited reduced its stake in the company by a total of 12.03 million shares through centralized bidding and block trading, accounting for 3% of the total share capital of the company, with a total reduction amount of approximately 142 million yuan, and the reduction plan has been completed. After the reduction, Dayong Limited remains a shareholder holding over 5% of the company, holding 76.8361 million shares, accounting for 19.16% of the total share capital of the company.
3. 15 days and 9 limit-ups for Guang'an Aizhong: The company's stock price has been limit-up for many days, and there is considerable risk of decline in the future.
Guang'an Aizhong Announcement, on December 11, 2024, the company's stock turnover rate was 11.73%, with a transaction amount of 919 million yuan. Since November 21, 2024, the company's stock has seen a limit-up closing price for 9 trading days, with a cumulative turnover rate of 257.64%. Given that the company's stock price has been limit-up for many days but the company's fundamentals have not undergone significant changes, there is a considerable risk of decline in the future. Investors are advised to make rational decisions and invest cautiously. After self-examination, the company has not found any media reports or market rumors that may have a significant impact on the company's stock trading price. As of the date of this announcement, the company is not involved in any major asset restructuring, acquisition of listed companies, or related planning, negotiations, intentions, agreements, and so on.
4. 20CM two consecutive limit-ups for Lexin Technology: No plans to engage in specific whole machine businesses.
Lexin Technology announced that the cumulative closing price deviation of the company's stock trading exceeded 30% within three consecutive trading days, falling under the category of abnormal stock trading fluctuations. Regarding rumors that Lexin Technology is a supplier of ByteDance's Doubao AI toy, providing whole machine supply business, the company clarifies the following: Lexin provides IoT chips, modules, and related software technology support for various industries, but has no plans to engage in specific whole machine businesses. Each industry usually has professional solution providers to create specific application solutions for particular industries.
5. Hubei Yihua: Plans to acquire 100% equity of Yichang New Development Investment for 3.208 billion yuan, constituting a major asset reorganization.
Hubei Yihua announced that the company plans to pay cash to acquire 100% equity of Yichang New Development Investment held by its controlling shareholder, Yihua Group, with a transaction price of 3.208 billion yuan, constituting a related party transaction and major asset reorganization. After the completion of this transaction, Yichang New Development Investment will become a wholly-owned subsidiary of the company, and the company's equity ratio in Xinjiang Yihua will increase to 75%. Yichang New Development Investment is a holding platform company that, besides holding a 39.403% equity stake in Xinjiang Yihua, does not hold equity in other companies and does not engage in specific businesses. Xinjiang Yihua mainly engages in the chemical fertilizer business, including PVC, caustic soda, and urea, while its important subsidiary, Yihua Mining, mainly engages in coal mining business. After the completion of this transaction, the company’s main business will be the production and sales of fertilizers, chemical products, and coal, forming a complete upstream and downstream industrial chain of chemicals.
6. Modern Investment: The company's independent director Xu Qing is suspected of serious disciplinary violations and is currently undergoing disciplinary review and investigation by the Discipline Inspection Commission of the Industrial and Commercial Bank of China Hunan Branch.
Modern Investment announced that independent director Xu Qing is suspected of serious disciplinary violations and is currently under disciplinary review and investigation by the Discipline Inspection Commission of the Industrial and Commercial Bank of China Hunan Branch and the Zhuzhou Municipal Supervisory Commission. Xu Qing, besides serving as the company's independent director, chairperson of the board's nomination committee, member of the board's strategy committee, and member of the board's audit committee, does not hold other positions in the company and does not participate in the company's daily operations and management. The company will pay attention to the subsequent developments and strictly fulfill its information disclosure obligations in accordance with relevant regulations.
7. Fudan Fuhua: There are currently no defined clients for the sales agency activities of Benyuan Quantum, and there are no sales project filings.
Fudan Fuhua announced an abnormal fluctuation in stock trading. On August 5, 2024, the company was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure. The strategic cooperation agreement signed with Benyuan Quantum on September 2, 2024, is a strategic cooperation framework agreement for both parties to strengthen market layout and build industry alliances related to sales services, stipulating that our company acts as a sales service consultant and is a non-exclusive agent. Benyuan Quantum has the right to entrust/authorize other agents to conduct sales activities within our company's agency area. This sales agency activity requires sales project filing, and there are currently no defined clients, and no sales project filings exist. This sales agency activity is not guaranteed to occur and is not a continuous business, exhibiting a certain degree of randomness.
8. 3 consecutive limit-ups for Huifa Food: Shareholder Zhenghechang reduced 1 million shares on December 11, and the reduction plan has not yet been completed.
Huifa Food announced that since December 9, 2024, the company's stock has experienced limit-up for three consecutive trading days. On November 8, 2024, the company disclosed the shareholder reduction plan announcement, stating that shareholder Zhenghechang Investment Co., Ltd. plans to reduce its stake by no more than 2.4464 million shares through centralized bidding, which does not exceed 1% of the total share capital of the company; and to reduce no more than 4.8928 million shares through block trading, which does not exceed 2% of the total share capital of the company. The reduction period is from November 29, 2024, to February 27, 2025. On December 11, 2024, Zhenghechang Investment Co., Ltd. reduced its shares by 1 million shares through centralized bidding trading. Currently, this shareholder's reduction plan has not been completed.
9. 6 days and 5 limit-ups for Ningbo Jingda: Both the company and Wuxi Weiyan do not involve humanoid robot products and businesses.
Ningbo Jingda issued a stock trading risk warning announcement. The company's main business is the research and development, production, and sales of stamping equipment, heat exchanger equipment, and micro-channel heat exchanger equipment. According to the company's self-examination, the production and operation situation is normal, and there have been no significant changes in the internal and external operating environment. Wuxi Weiyan's main business involves the research and development, production, and sales of precision molds, precision stamped parts, and micro-hole electric discharge machines. Both the company and Wuxi Weiyan do not involve humanoid robot products and businesses.
Article forwarded from: Jin Ten Data.